School of Medicine


Showing 11-20 of 31 Results

  • Nicholas Bassano

    Nicholas Bassano

    Clinical Research Coordinator 2, Psych/General Psychiatry and Psychology (Adult)

    Current Role at Stanford Clinical Research Coordinator-2
    Stanford University Department of Psychiatry and Behavioral Science
    Brain Stimulation Lab

  • Nataly Sumarriva Beck

    Nataly Sumarriva Beck

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Dr. Beck's clinical research includes the relationship between catatonia and substance use. In addition, she works on first-episode psychosis, with a focus on treatments in the young adult population.

  • Ori-Michael Johanan Benhamou

    Ori-Michael Johanan Benhamou

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Benhamou received his Bachelor's degree at Duke University and went on to complete medical school at Ben-Gurion University. He completed his residency in Psychiatry at Westchester Medical Center and fellowship in Addiction Medicine at Stanford. He has published works in the areas of suicide, autoimmune encephalitis and addiction. His current interests include substance abuse, the role of transcranial magnetic stimulation on addiction and the intersection of suicide and substance abuse.

  • Brandon S. Bentzley, MD, PhD

    Brandon S. Bentzley, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Bentzley is a psychiatrist and Instructor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.

    His clinical interests include the treatment of substance use disorders and depression using advanced techniques and technologies such as neurostimulation. His research interests include advances in neurostimulation-based treatments, suicide prevention and neuroeconomics.

    As a postdoctoral fellow, Dr. Bentzley was the recipient of a National Institute of Mental Health research training grant. Currently, he is principal investigator on a study funded by the National Institute on Drug Abuse that focuses on understanding the role of dopamine in economic decision making. Further, Dr. Bentzley is co-investigator of a study that received grant support from the American Foundation for Suicide Prevention. This randomized, controlled trial investigates ketamine therapy with a transition to buprenorphine for the treatment of acute suicidality. The study is scheduled for completion in 2022.

    Dr. Bentzley is also a consultant for industry innovators, such as an organization conducting research into new treatments for opioid use disorder and another focusing on data science and psychometrics.

    He has authored articles on surgically implanted neuromodulatory technology for treatment-resistant depression, the origins of selective vulnerability to opioid addiction, the antidepressant effects of ketamine, the role of neurons in cocaine demand, and other topics.

    His work has appeared in the American Journal of Psychiatry, Proceedings of the National Academy of Sciences, Molecular Psychiatry, and elsewhere. In addition, he is a reviewer for the Journal of Substance Abuse Treatment, European Journal of Neuroscience, Behavioural Brain Research, and Addiction Biology.

    Dr. Bentzley has delivered invited lectures including psychiatry grand grounds at Stanford and other medical centers. He has held leadership positions on committees focused on medical education and residency programs, among them Stanford?s Psychiatry Residency Neuroscience Curriculum Committee and the Psychiatry Residency Wellbeing Committee.

    Dr. Bentzley has received honors for his scholarship. He was a member of a team that won the American Psychiatric Association?s ?MindGames? national residency competition, was a Ruth Fox Scholar, as designated by the American Society of Addiction Medicine, and won the Distinguished Graduate of the Year Award from the Medical University of South Carolina.

    He is a member of the American Psychiatric Association, American Society of Addiction Medicine, American Society for Neurosciences, and American Association for the Advancement of Science. Dr. Bentzley has provided community outreach mental health services as a clinical volunteer.

  • Mahendra Bhati

    Mahendra Bhati

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Bhati is a board certified neuropsychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia and was a principle investigator for the DSM-5 academic field trials. His research experience included roles as an investigator in the first controlled clinical trials of deep brain stimulation and low field synchronized TMS for treatment of depression. His current interests include studying TMS-evoked potentials as biomarkers for neuropsychiatric disorders, augmented-reality TMS, closed-loop responsive neurostimulation for treatment of impulse and fear-related disorders, and magnetic resonance guided focused ultrasound for treatment-resistant obsessive compulsive disorder and depression.

Footer Links:

Stanford Medicine Resources: